(Q41096841)

26 September 2017

1 reference

title

Adverse clinical effects of immune sorption with staphylococcal protein A columns (English)

1 reference

26 September 2017

Huestis DW

1

1 reference

26 September 2017

Morrison FS

series ordinal

2

1 reference

26 September 2017

publication date

1 January 1996

1 reference

Transfusion Medicine Reviews

26 September 2017

published in

1 reference

26 September 2017

volume

10

1 reference

26 September 2017

issue

1

1 reference

26 September 2017

page(s)

62-70

1 reference

Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Treatment of refractoriness to platelet transfusion by protein A column therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

An evaluation of intravenous immunoglobulin in the treatment of human immunodeficiency virus-associated thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Use of protein A immunoadsorption as a treatment for thrombocytopenia in HIV-infected homosexual men: a retrospective evaluation of 37 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

The use of protein A columns in the treatment of cancer and allied diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Minimal toxicity during protein A immunoadsorption treatment of malignant disease: an outpatient therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Feasibility of extracorporeal on-line large-scale plasma adsorptions on protein A-sepharose columns in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

The application of protein A immunoadsorption to remove platelet alloantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Treatment of congenital and acquired hemophilia patients by extracorporeal removal of antibodies to coagulation factors: a review of US clinical studies 1987-1990. Hemophilia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Kinetic Aspects of the Removal of IgG and Inhibitors in Hemophiliacs Using Protein A Immunoadsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Immunoadsorption for coagulation factor inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Treatment of rapidly progressive glomerulonephritis by extracorporeal immunoadsorption, prednisolone and cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Extracorporeal removal of anti-HLA antibodies in transplant candidates

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Immunoadsorption in the sensitized transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Mortality in therapeutic haemapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Complications of plasma exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Complications of therapeutic plasma exchange: a recent assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Protein A immunoadsorption in the treatment of malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Ex vivo and in vivo protein A perfusion: background, basic investigations, and first clinical experiences

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Immunoadsorption with protein A sepharose or silica

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Toxicity following protein A treatment of metastatic breast adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

An unexpected complication following immunoadsorption with a staphylococcal protein A column

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Life-threatening reaction to staphylococcal protein A immunomodulation

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Severe adverse effects of protein A immunoadsorption

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

LDL-apheresis with dextran sulphate and anaphylactoid reactions to ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Anaphylactoid reactions, LDL apheresis with dextran sulphate, and ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Atypical reactions associated with use of angiotensin-converting enzyme inhibitors and apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

Prevention with icatibant of anaphylactoid reactions to ACE inhibitor during LDL apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0887-7963%2896%2980123-4

7 January 2021

10.1016/S0887-7963(96)80123-4

Identifiers

DOI

1 reference

26 September 2017

1 reference